Dale Yuzuki

Dale is a trained molecular biologist with over 7 years of clinical research and 23 years of corporate experience in biotechnology. Dale marketed and sold microarray and next-generation sequencing instruments in the field for Illumina for 6 years before joining Life Technologies which was later purchased by Thermo Fisher as Illumina’s largest competitor in clinical sequencing. He has also worked for 6 years at Qiagen after starting his career as a cancer and immunology researcher at the John Wayne Institute. Dale more recently worked for SeraCare Life Sciences, Pillar Biosciences, Helligenics and works closely with various oncology and liquid biopsy startups today.